Anticonvulsant derivatives useful in treating obesity
Patent 6071537 Issued on June 6, 2000. Estimated Expiration Date: 
June 23, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 23, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesAnticonvulsant sulfamate derivatives Anticonvulsant fructopyranose cyclic sulfites and sulfates Patent #: 5242942 InventorAssigneeApplicationNo. 881009 filed on 06/23/1997US Classes:424/464, Tablets, lozenges, or pills424/400, PREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORM424/451, Capsules (e.g., of gelatin, of chocolate, etc.)424/489, Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)514/23Carbohydrate (i.e., saccharide radical containing) DOAIExaminersPrimary: Spear, James M.Attorney, Agent or FirmInternational ClassesA61K 009/20A61K 009/48 A61K 031/35 AbstractA method for treating obesity comprising administering a therapeutically effective amount of a compound of the formula: ##STR1## is disclosed.Other References
Field of SearchCapsules (e.g., of gelatin, of chocolate, etc.)Tablets, lozenges, or pills Particulate form (e.g., powders, granules, beads, microcapsules, and pellets) PREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORM Anal, rectal (e.g., suppositories, etc.) Surgical implant or material OBESITY DISPERSION OR EMULSION Carbohydrate (i.e., saccharide radical containing) DOAI | |
